164 related articles for article (PubMed ID: 28018929)
1. Antiretroviral Therapy as Prevention of … Pneumococcal Infections?
Lesourd A; Leporrier J; Delbos V; Unal G; Honoré P; Etienne M; Bouchaud O; Caron F
Open Forum Infect Dis; 2016 Oct; 3(4):ofw228. PubMed ID: 28018929
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of invasive bacterial infections in pneumococcal conjugate vaccine-vaccinated and -unvaccinated children under 5 years of age in Soweto, South Africa: a cohort study from a high-HIV burden setting.
Johnstone SL; Moore DP; Klugman KP; Madhi SA; Groome MJ
Paediatr Int Child Health; 2020 Feb; 40(1):50-57. PubMed ID: 31156062
[No Abstract] [Full Text] [Related]
3. Community-Acquired Pneumococcal Pneumonia in Virologically Suppressed HIV-Infected Adult Patients: A Matched Case-Control Study.
Cillóniz C; Torres A; Manzardo C; Gabarrús A; Ambrosioni J; Salazar A; García F; Ceccato A; Mensa J; de la Bella Casa JP; Moreno A; Miró JM
Chest; 2017 Aug; 152(2):295-303. PubMed ID: 28302496
[TBL] [Abstract][Full Text] [Related]
4. Invasive Pneumococcal Disease Among HIV-Infected and HIV-Uninfected Adults in a Large Integrated Healthcare System.
Marcus JL; Baxter R; Leyden WA; Muthulingam D; Yee A; Horberg MA; Klein DB; Towner WJ; Chao CR; Quesenberry CP; Silverberg MJ
AIDS Patient Care STDS; 2016 Oct; 30(10):463-470. PubMed ID: 27749111
[TBL] [Abstract][Full Text] [Related]
5. Vaccination coverage against hepatitis A and B viruses, Streptococcus pneumoniae, seasonal flu, and A(H1N1)2009 pandemic influenza in HIV-infected patients.
Valour F; Cotte L; Voirin N; Godinot M; Ader F; Ferry T; Vanhems P; Chidiac C
Vaccine; 2014 Jul; 32(35):4558-4564. PubMed ID: 24951870
[TBL] [Abstract][Full Text] [Related]
6. Pneumococcal vaccination coverage in France by general practitioners in adults with a high risk of pneumococcal disease.
Kopp A; Mangin O; Gantzer L; Lekens B; Simoneau G; Ravelomanantsoa M; Evans J; Bergmann JF; Sellier P
Hum Vaccin Immunother; 2021 Jan; 17(1):162-169. PubMed ID: 32429734
[No Abstract] [Full Text] [Related]
7. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy.
Grau I; Pallares R; Tubau F; Schulze MH; Llopis F; Podzamczer D; Liñares J; Gudiol F;
Arch Intern Med; 2005 Jul; 165(13):1533-40. PubMed ID: 16009870
[TBL] [Abstract][Full Text] [Related]
8. Incidence and Risk Factors for Invasive Pneumococcal Disease and Community-acquired Pneumonia in Human Immunodeficiency Virus-Infected Individuals in a High-income Setting.
Garcia Garrido HM; Mak AMR; Wit FWNM; Wong GWM; Knol MJ; Vollaard A; Tanck MWT; Van Der Ende A; Grobusch MP; Goorhuis A
Clin Infect Dis; 2020 Jun; 71(1):41-50. PubMed ID: 31634398
[TBL] [Abstract][Full Text] [Related]
9. Pneumococcal vaccination among HIV-infected adult patients in the era of combination antiretroviral therapy.
Lee KY; Tsai MS; Kuo KC; Tsai JC; Sun HY; Cheng AC; Chang SY; Lee CH; Hung CC
Hum Vaccin Immunother; 2014; 10(12):3700-10. PubMed ID: 25483681
[TBL] [Abstract][Full Text] [Related]
10. Incidence and risk factors for invasive pneumococcal disease in HIV-positive individuals in the era of highly active antiretroviral therapy.
Sadlier C; O'Connell S; Kelleher M; Bergin C
Int J STD AIDS; 2019 Apr; 30(5):472-478. PubMed ID: 30999829
[TBL] [Abstract][Full Text] [Related]
11. Recurrent invasive pneumococcal disease in children--host factors and vaccination response.
Ingels HA
Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183055
[TBL] [Abstract][Full Text] [Related]
12. Invasive pneumococcal disease in HIV-infected adults in France from 2000 to 2011: antimicrobial susceptibility and implication of serotypes for vaccination.
Munier AL; de Lastours V; Varon E; Donay JL; Porcher R; Molina JM
Infection; 2013 Jun; 41(3):663-8. PubMed ID: 23404685
[TBL] [Abstract][Full Text] [Related]
13. Influenza and pneumococcal vaccination of HIV-infected patients: a policy analysis.
Rose DN; Schechter CB; Sacks HS
Am J Med; 1993 Feb; 94(2):160-8. PubMed ID: 8094271
[TBL] [Abstract][Full Text] [Related]
14. [Which are the vaccines that human immunodeficiency virus infected patients must receive?].
Valencia Ortega ME; González Lahoz JM
An Med Interna; 1998 Aug; 15(8):439-42. PubMed ID: 9780428
[TBL] [Abstract][Full Text] [Related]
15. Preventing bacterial respiratory tract infections among persons infected with human immunodeficiency virus.
Keller DW; Breiman RF
Clin Infect Dis; 1995 Aug; 21 Suppl 1():S77-83. PubMed ID: 8547517
[TBL] [Abstract][Full Text] [Related]
16. [Impact of an intervention to improve the vaccination coverage against
Hernández-García I; Román-Calderón F; López-Mendoza H; Aibar-Remón C;
Rev Esp Salud Publica; 2019 Dec; 93():. PubMed ID: 31782756
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for invasive pneumococcal disease in HIV-infected adults in France in the highly active antiretroviral therapy era.
Munier AL; de Lastours V; Porcher R; Donay JL; Pons JL; Molina JM
Int J STD AIDS; 2014 Dec; 25(14):1022-8. PubMed ID: 24676129
[TBL] [Abstract][Full Text] [Related]
18. [Immunological effect of vaccination against pneumococcal infection in HIV-infected children].
Pakhomov DV; Kostinov MP; Poddubikov AV; Vaneeva NP; Snegova NF; Nikitina TN; Zinkina TN; Suloeva SV
Zh Mikrobiol Epidemiol Immunobiol; 2009; (2):48-52. PubMed ID: 19459477
[TBL] [Abstract][Full Text] [Related]
19. The persisting burden of invasive pneumococcal disease in HIV patients: an observational cohort study.
Siemieniuk RA; Gregson DB; Gill MJ
BMC Infect Dis; 2011 Nov; 11():314. PubMed ID: 22078162
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
